Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Assessing the magnitude and costs of intraoperative inefficiencies attributable to surgical instrument trays.

Stockert EW, Langerman A.

J Am Coll Surg. 2014 Oct;219(4):646-55. doi: 10.1016/j.jamcollsurg.2014.06.019. Epub 2014 Jul 11.

PMID:
25154669
2.

Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.

Garrett TP, Burgess AW, Gan HK, Luwor RB, Cartwright G, Walker F, Orchard SG, Clayton AH, Nice EC, Rothacker J, Catimel B, Cavenee WK, Old LJ, Stockert E, Ritter G, Adams TE, Hoyne PA, Wittrup D, Chao G, Cochran JR, Luo C, Lou M, Huyton T, Xu Y, Fairlie WD, Yao S, Scott AM, Johns TG.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5082-7. doi: 10.1073/pnas.0811559106. Epub 2009 Mar 16.

3.

Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.

Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gnjatic S, Stockert E, Driscoll D, Lele S, Old LJ, Odunsi K.

Clin Cancer Res. 2006 Jan 15;12(2):398-404. Erratum in: Clin Cancer Res. 2006 Mar 1;12(5):1656. Gjnatic, Sacha [corrected to Gnjatic, Sacha].

4.

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG.

Clin Cancer Res. 2005 Sep 1;11(17):6390-9.

5.

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J.

Clin Cancer Res. 2004 Dec 15;10(24):8396-404.

6.

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.

Sugita Y, Wada H, Fujita S, Nakata T, Sato S, Noguchi Y, Jungbluth AA, Yamaguchi M, Chen YT, Stockert E, Gnjatic S, Williamson B, Scanlan MJ, Ono T, Sakita I, Yasui M, Miyoshi Y, Tamaki Y, Matsuura N, Noguchi S, Old LJ, Nakayama E, Monden M.

Cancer Res. 2004 Mar 15;64(6):2199-204.

7.

Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.

Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ, Gnjatic S.

J Immunol. 2004 Mar 1;172(5):3289-96.

8.

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.

Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ.

Cancer Immun. 2003 Dec 18;3:19.

9.

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

Johns TG, Luwor RB, Murone C, Walker F, Weinstock J, Vitali AA, Perera RM, Jungbluth AA, Stockert E, Old LJ, Nice EC, Burgess AW, Scott AM.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15871-6. Epub 2003 Dec 15.

10.

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C.

Cancer Res. 2003 Oct 15;63(20):6948-55.

11.

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ.

Cancer Res. 2003 Sep 15;63(18):6076-83.

12.

Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.

Tahtis K, Lee FT, Wheatley JM, Garin-Chesa P, Park JE, Smyth FE, Obata Y, Stockert E, Hall CM, Old LJ, Rettig WJ, Scott AM.

Mol Cancer Ther. 2003 Aug;2(8):729-37.

13.

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.

Nakada T, Noguchi Y, Satoh S, Ono T, Saika T, Kurashige T, Gnjatic S, Ritter G, Chen YT, Stockert E, Nasu Y, Tsushima T, Kumon H, Old LJ, Nakayama E.

Cancer Immun. 2003 Jul 31;3:10.

14.

Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.

Mischo A, Wadle A, Wätzig K, Jäger D, Stockert E, Santiago D, Ritter G, Regitz E, Jäger E, Knuth A, Old L, Pfreundschuh M, Renner C.

Cancer Immun. 2003 Jun 27;3:5.

15.

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.

Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ.

Cancer Immun. 2001 Mar 30;1:4.

16.

Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.

Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A.

Cancer Immun. 2002 Sep 19;2:12.

17.

Expression of cancer-testis genes in human hepatocellular carcinomas.

Luo G, Huang S, Xie X, Stockert E, Chen YT, Kubuschok B, Pfreundschuh M.

Cancer Immun. 2002 Sep 19;2:11.

18.

Urine antibody against human cancer antigen NY-ESO-1.

Jäger D, Stockert E, Karbach J, Herrlinger K, Atmaca A, Arand M, Chen YT, Gnjatic S, Old LJ, Knuth A, Jäger E.

Cancer Immun. 2002 Aug 6;2:10.

19.

Immunomic analysis of human sarcoma.

Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2651-6. Epub 2003 Feb 24.

20.

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.

Jungbluth AA, Stockert E, Huang HJ, Collins VP, Coplan K, Iversen K, Kolb D, Johns TJ, Scott AM, Gullick WJ, Ritter G, Cohen L, Scanlan MJ, Cavenee WK, Old LJ.

Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):639-44. Epub 2003 Jan 6. Erratum in: Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2163. Cavanee, Webster K [corrected to Cavenee, Webster K].

21.

Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.

Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jäger D, Jäger E, Knuth A, Old LJ.

Cancer Res. 2002 Jul 15;62(14):4041-7.

22.

CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.

Jungbluth AA, Chen YT, Busam KJ, Coplan K, Kolb D, Iversen K, Williamson B, Van Landeghem FK, Stockert E, Old LJ.

Int J Cancer. 2002 Jun 20;99(6):839-45.

23.

Identification of cancer/testis genes by database mining and mRNA expression analysis.

Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jäger D, Jäger E, Knuth A, Old LJ.

Int J Cancer. 2002 Apr 1;98(4):485-92.

24.

Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.

Johns TG, Stockert E, Ritter G, Jungbluth AA, Huang HJ, Cavenee WK, Smyth FE, Hall CM, Watson N, Nice EC, Gullick WJ, Old LJ, Burgess AW, Scott AM.

Int J Cancer. 2002 Mar 20;98(3):398-408.

25.

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.

Jungbluth AA, Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, Chen YT, Stockert E, Ladanyi M, Old LJ.

Int J Cancer. 2001 Oct 15;94(2):252-6.

26.

Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.

Mishima K, Johns TG, Luwor RB, Scott AM, Stockert E, Jungbluth AA, Ji XD, Suvarna P, Voland JR, Old LJ, Huang HJ, Cavenee WK.

Cancer Res. 2001 Jul 15;61(14):5349-54. Erratum in: Cancer Res 2001 Oct 15;61(20):7703-5.

27.

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, Nakayama E.

Cancer Res. 2001 Jun 15;61(12):4671-4.

28.

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.

Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ.

Int J Cancer. 2001 Jun 15;92(6):856-60. Erratum in: Int J Cancer 2002 Feb 20;97(6):878.

29.

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.

Jäger D, Stockert E, Güre AO, Scanlan MJ, Karbach J, Jäger E, Knuth A, Old LJ, Chen YT.

Cancer Res. 2001 Mar 1;61(5):2055-61.

30.

Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.

Jungbluth AA, King R, Fisher DE, Iversen K, Coplan K, Kolb D, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ.

Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):29-34.

PMID:
11277411
31.

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.

Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, Guillaume P, Speiser D, Stockert E, Spagnoli G, Servis C, Cerottini JC, Lejeune F, Romero P, Valmori D.

J Immunol. 2000 Dec 15;165(12):7253-61.

32.

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

Jäger E, Gnjatic S, Nagata Y, Stockert E, Jäger D, Karbach J, Neumann A, Rieckenberg J, Chen YT, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12198-203.

33.

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10917-22.

34.

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.

Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam KJ, Old LJ.

Br J Cancer. 2000 Aug;83(4):493-7.

35.

Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library.

Jäger D, Stockert E, Jäger E, Güre AO, Scanlan MJ, Knuth A, Old LJ, Chen YT.

Cancer Res. 2000 Jul 1;60(13):3584-91.

36.

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

Chen JL, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V.

J Immunol. 2000 Jul 15;165(2):948-55.

37.

Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.

Scott AM, Geleick D, Rubira M, Clarke K, Nice EC, Smyth FE, Stockert E, Richards EC, Carr FJ, Harris WJ, Armour KL, Rood J, Kypridis A, Kronina V, Murphy R, Lee FT, Liu Z, Kitamura K, Ritter G, Laughton K, Hoffman E, Burgess AW, Old LJ.

Cancer Res. 2000 Jun 15;60(12):3254-61.

38.

T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.

Jungbluth AA, Iversen K, Coplan K, Kolb D, Stockert E, Chen YT, Old LJ, Busam K.

Pathol Res Pract. 2000;196(4):235-42.

PMID:
10782467
39.

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A.

Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4760-5.

40.

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.

Güre AO, Stockert E, Scanlan MJ, Keresztes RS, Jäger D, Altorki NK, Old LJ, Chen YT.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4198-203.

41.

CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.

Güre AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT.

Int J Cancer. 2000 Mar 1;85(5):726-32.

42.

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.

Jäger E, Jäger D, Karbach J, Chen YT, Ritter G, Nagata Y, Gnjatic S, Stockert E, Arand M, Old LJ, Knuth A.

J Exp Med. 2000 Feb 21;191(4):625-30.

43.

Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.

Jäger D, Stockert E, Scanlan MJ, Güre AO, Jäger E, Knuth A, Old LJ, Chen YT.

Cancer Res. 1999 Dec 15;59(24):6197-204.

44.

Antigens recognized by autologous antibody in patients with renal-cell carcinoma.

Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ.

Int J Cancer. 1999 Nov 12;83(4):456-64.

45.

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.

Jäger E, Stockert E, Zidianakis Z, Chen YT, Karbach J, Jäger D, Arand M, Ritter G, Old LJ, Knuth A.

Int J Cancer. 1999 Oct 22;84(5):506-10.

46.

Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.

Jungbluth AA, Iversen K, Coplan K, Williamson B, Chen YT, Stockert E, Old LJ, Busam KJ.

Virchows Arch. 1999 May;434(5):429-35.

PMID:
10389626
47.

Isoforms of the human PDZ-73 protein exhibit differential tissue expression.

Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old LJ.

Biochim Biophys Acta. 1999 Apr 14;1445(1):39-52.

PMID:
10209257
48.

Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.

Busam KJ, Chen YT, Old LJ, Stockert E, Iversen K, Coplan KA, Rosai J, Barnhill RL, Jungbluth AA.

Am J Surg Pathol. 1998 Aug;22(8):976-82.

PMID:
9706977
49.

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.

Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7556-61.

50.

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.

Chen YT, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A, Old LJ.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6919-23.

Supplemental Content

Loading ...
Support Center